A Clinical Study Evaluating the Preliminary Anti-tumor Efficacy and Safety of Hemay181

NCT07446816 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: Hemay181

Sponsor

Ganzhou Hemay Pharmaceutical Co., Ltd